Patency of Wallstents placed across the venous anastomosis of hemodialysis grafts after percutaneous recanalization

Radiology. 1998 Nov;209(2):365-70. doi: 10.1148/radiology.209.2.9807560.

Abstract

Purpose: To determine the patency of Wallstents placed across the venous anastomosis of prosthetic bridge grafts after percutaneous graft recanalization.

Materials and methods: Wallstents were placed across 26 lesions at the venous anastomosis of polytetrafluoroethylene (PTFE) grafts in 25 patients (11 men, 14 women; age range, 29-83 years; mean age, 65.4 years) after pulse-spray pharmacomechanical thrombolysis. Indications for stent deployment included acute angioplasty failure, rapid restenosis, and vessel perforation.

Results: The initial success rate was 100%. The mean primary graft patency rates (+/- standard error) at 3 and 6 months were 34% +/- 9 and 27% +/- 9, respectively. Secondary patency rates were 77% +/- 8 at 3 months, 72% +/- 9 at 6 months, and 50% +/- 10 at 12 months. Eight of the 26 grafts continued to be used for hemodialysis at the end of follow-up.

Conclusion: After angioplasty failure or vessel perforation, Wallstent placement at the venous anastomosis of recanalized PTFE grafts can salvage hemodialysis access function. The results of this study indicate that the 1-year secondary patency rate of these grafts is 50%, which approaches the reported rates of patency after balloon dilation as part of percutaneous graft recanalization.

MeSH terms

  • Aged
  • Anastomosis, Surgical
  • Angioplasty, Balloon
  • Blood Vessel Prosthesis*
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Follow-Up Studies
  • Graft Occlusion, Vascular / therapy*
  • Heparin / administration & dosage
  • Humans
  • Male
  • Polytetrafluoroethylene
  • Renal Dialysis*
  • Stents*
  • Thrombolytic Therapy
  • Time Factors
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Vascular Patency

Substances

  • Fibrinolytic Agents
  • Polytetrafluoroethylene
  • Heparin
  • Urokinase-Type Plasminogen Activator